NOTCH4 and atherosclerosis: These data demonstrate a fundamental role for JAG1-NOTCH4 in sensing disease-priming LOSS and suggest that therapeutic targeting of JAG1-NOTCH4 could be a novel treatment strategy to enhance reparative EC subsets to prevent or treat atherosclerosis.